[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) shareholder Brian Kneafsey has filed a Rule 144 notice to sell 25,000 shares of common stock through Charles Schwab & Co., Inc. The planned sale has an aggregate market value of $74,732.00 and is listed for execution on the NYSE around 11/17/2025. The filing indicates there are 256,119,535 shares of this class outstanding.

The 25,000 shares to be sold were acquired on 02/17/2020 via an exercise-and-hold transaction from Blend Labs, Inc., paid in cash. Over the past three months, Kneafsey has already sold 25,000 Blend Labs securities on 09/15/2025 for gross proceeds of $109,069.00 and another 25,000 on 10/15/2025 for $83,509.00. By signing, the seller represents they are not aware of any undisclosed material adverse information about Blend Labs.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	25000	74732.00	256119535	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2020	Exercise and Hold	BLEND LABS, INC.			25000	02/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	09/15/2025	25000	109069.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	10/15/2025	25000	83509.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for BLND disclose?

The Form 144 discloses that Brian Kneafsey plans to sell 25,000 shares of Blend Labs, Inc. common stock on the NYSE under Rule 144, with an aggregate market value of $74,732.00.

How many Blend Labs (BLND) shares is the shareholder planning to sell?

The shareholder has filed to sell 25,000 shares of Blend Labs common stock, with an indicated aggregate market value of $74,732.00.

How many Blend Labs (BLND) shares are outstanding in this class?

The filing lists 256,119,535 shares of the relevant class of Blend Labs common stock as outstanding.

When and how were the BLND shares being sold acquired?

The 25,000 shares to be sold were acquired on 02/17/2020 through an Exercise and Hold transaction from Blend Labs, Inc., with the purchase price paid in cash.

What recent sales of Blend Labs (BLND) stock has the seller made?

During the past three months, the seller disposed of 25,000 Blend Labs securities on 09/15/2025 for $109,069.00 and another 25,000 on 10/15/2025 for $83,509.00 in gross proceeds.

Which broker and exchange are involved in the planned BLND sale?

The planned sale of 25,000 Blend Labs common shares is to be executed through Charles Schwab & Co., Inc. on the NYSE.

What representation does the seller make about information on Blend Labs?

By signing the notice, the seller represents that they do not know any material adverse information about Blend Labs’ current or prospective operations that has not been publicly disclosed.